IntroducedSep 14, 2021
Signed into Law
A bill to establish a strategic active pharmaceutical ingredient reserve to maintain a domestic supply of active pharmaceutical ingredients and key starting materials needed for the manufacturing of essential generic medicines, and to build a pipeline for domestic active pharmaceutical ingredient production.
Senate • Sep 14, 2021: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Do you support this bill?
Official Summary/Bill Text
- Sep 14, 2021 | Senate
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.